Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of Epoetin Alfa on Hemoglobin, Symptom Distress, and Quality of Life in Patients Receiving Chemotherapy

This study has been completed.
Sponsor:
Information provided by:
Ortho Biotech Clinical Affairs, L.L.C.
ClinicalTrials.gov Identifier:
NCT00524407
First received: August 30, 2007
Last updated: April 1, 2010
Last verified: April 2010